All Type of News
Yungjin to distribute B. Brown Medical’s enteral nutrition products
Yungjin Pharmaceutical said last Thursday that it has signed a distribution agreement with B. Brown Korea for the sale of B. Brown Medical’s enteral nutrition products here.
The agreement will further strengthen Yu...
Kowa’s topical analgesic product to expand Korean market
Kowa Korea, a local unit of Japan’s Kowa Pharmaceutical Co., has recently released its OTC product Vantelin Kowa (indomethacin), one of the top topical analgesic products in Japan.
With its flagship product, which ...
Korean biopharmaceutical companies urged to boost revenue
The founder and chief executive officer of Celltrion, Seo Jung-jin, made a surprising announcement last Tuesday stating that he would offload his 97.3 percent controlling stake in the company. He said he plans to sell...
Korean biopharmaceutical companies face dismal outlook
In the early 2000s, Korea was basking in the biotechnology boom thanks largely to advanced stem cell research. Strong government support led many research centers to open up bio-related facilities including cord blood...
Doctors, drugmakers call for broader scope of marketing activities
Doctors and pharmaceutical companies have recently called on the government to revise regulations relating to the system that they called ”ambiguous“ in distinguishing between legal and illegal marketing acts.
In a...
Beefed-up audits heighten tension among drug makers
Local drug firms are in panic mode ahead of audits by the National Tax Service (NTS), which plans to examine pharmaceutical companies accused of providing kickbacks to doctors or hospitals in return for prescribing th...
People diagnosed with dementia aged over 65 triple in 6 years
The number of Koreans suffering from dementia more than tripled over the past six years fueled by the rapid aging of the country's population, a report by the National Health Insurance Corporation (NHIC) showed Sunday...
Celltrion shares keep fluctuating
Celltrion shares have been still fluctuating after Chairman Seo Jung-jin’s surprise announcement about selling his controlling stake in a biosimilar drugs company to a multinational firm.
Its stock fell on Thursday...
Wholesalers, SNUH at odds
Drug wholesalers has recently expressed “deep regret” about Seoul National University Hospital’s notice, through EZmedicom, to extend the effective date of supply agreement with existing associate wholesalers by one m...
Chang Byung-won tapped as new KFDA deputy chiefThe Korea Food and Drug Administration (KFDA) has tapped its senior official Chang Byung-won as its new deputy chief, the health watchdog said today.
Chang served various po...
|
